USD 457.63
(-1.29%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | -82.1 Million USD | -217.96% |
2022 | 69.6 Million USD | -20.0% |
2021 | 87 Million USD | 50.0% |
2020 | 58 Million USD | 0.0% |
2019 | - USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 100.0% |
2009 | -53.34 Million USD | -43.51% |
2008 | -37.17 Million USD | -89.64% |
2007 | -19.6 Million USD | 0.0% |
2006 | - USD | 100.0% |
2005 | -35.95 Million USD | 0.0% |
2004 | - USD | -100.0% |
2003 | 695 Thousand USD | -62.19% |
2002 | 1.83 Million USD | 138.39% |
2001 | 771 Thousand USD | -58.57% |
2000 | 1.86 Million USD | -26.18% |
1999 | 2.52 Million USD | 3.4% |
1998 | 2.43 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2024 Q3 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | -82.1 Million USD | 0.0% |
2023 FY | -82.1 Million USD | -217.96% |
2023 Q1 | - USD | -100.0% |
2023 Q2 | - USD | 0.0% |
2022 FY | 69.6 Million USD | -20.0% |
2022 Q3 | - USD | 0.0% |
2022 Q1 | - USD | -100.0% |
2022 Q4 | 69.6 Million USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2021 Q1 | - USD | -100.0% |
2021 FY | 87 Million USD | 50.0% |
2021 Q2 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | 87 Million USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2020 Q4 | 58 Million USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 FY | 58 Million USD | 0.0% |
2019 Q4 | - USD | -100.0% |
2019 Q3 | 72.2 Million USD | 3.74% |
2019 FY | - USD | 0.0% |
2019 Q1 | 71.3 Million USD | 0.0% |
2019 Q2 | 69.6 Million USD | -2.38% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2010 Q3 | - USD | 0.0% |
2010 FY | - USD | 100.0% |
2010 Q4 | - USD | 0.0% |
2010 Q2 | - USD | 0.0% |
2010 Q1 | - USD | 100.0% |
2009 Q1 | - USD | 100.0% |
2009 Q4 | -53.34 Million USD | 0.0% |
2009 FY | -53.34 Million USD | -43.51% |
2009 Q3 | - USD | 0.0% |
2009 Q2 | - USD | 0.0% |
2008 FY | -37.17 Million USD | -89.64% |
2008 Q4 | -37.17 Million USD | -7.87% |
2008 Q3 | -34.45 Million USD | -24.19% |
2008 Q2 | -27.74 Million USD | -18.87% |
2008 Q1 | -23.34 Million USD | -19.09% |
2007 Q1 | - USD | 0.0% |
2007 Q4 | -19.6 Million USD | 0.0% |
2007 FY | -19.6 Million USD | 0.0% |
2007 Q3 | - USD | 0.0% |
2007 Q2 | - USD | 0.0% |
2006 Q2 | -16.07 Million USD | -2.29% |
2006 FY | - USD | 100.0% |
2006 Q3 | -16.16 Million USD | -0.57% |
2006 Q4 | - USD | 100.0% |
2006 Q1 | -15.71 Million USD | 56.3% |
2005 Q3 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 FY | -35.95 Million USD | 0.0% |
2005 Q4 | -35.95 Million USD | 0.0% |
2004 Q3 | 52 Thousand USD | -77.39% |
2004 FY | - USD | -100.0% |
2004 Q1 | 435 Thousand USD | -37.41% |
2004 Q4 | - USD | -100.0% |
2004 Q2 | 230 Thousand USD | -47.13% |
2003 Q4 | 695 Thousand USD | -26.84% |
2003 Q2 | 1.23 Million USD | -19.33% |
2003 Q1 | 1.53 Million USD | -16.7% |
2003 Q3 | 950 Thousand USD | -23.08% |
2003 FY | 695 Thousand USD | -62.19% |
2002 Q4 | 1.83 Million USD | 2.57% |
2002 Q2 | 971 Thousand USD | -24.26% |
2002 Q1 | 1.28 Million USD | 66.28% |
2002 FY | 1.83 Million USD | 138.39% |
2002 Q3 | 1.79 Million USD | 84.55% |
2001 Q2 | 772 Thousand USD | -47.59% |
2001 FY | 771 Thousand USD | -58.57% |
2001 Q4 | 771 Thousand USD | -19.94% |
2001 Q3 | 963 Thousand USD | 24.74% |
2001 Q1 | 1.47 Million USD | -20.85% |
2000 Q1 | 2.47 Million USD | 0.0% |
2000 Q4 | 1.86 Million USD | 49.96% |
2000 Q3 | 1.24 Million USD | -39.11% |
2000 Q2 | 2.03 Million USD | -17.52% |
2000 FY | 1.86 Million USD | -26.18% |
1999 FY | 2.52 Million USD | 3.4% |
1998 FY | 2.43 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 75.25 Million USD | 209.097% |
AngioDynamics, Inc. | 3.93 Million USD | 2184.285% |
AtriCure, Inc. | 60.59 Million USD | 235.494% |
Avinger, Inc. | - USD | Infinity% |
Azenta, Inc. | 60.43 Million USD | 235.846% |
BioLife Solutions, Inc. | 18.31 Million USD | 548.364% |
The Cooper Companies, Inc. | 2.52 Billion USD | 103.253% |
Daxor Corporation | 755.65 Thousand USD | 10964.689% |
Ekso Bionics Holdings, Inc. | 4.83 Million USD | 1799.089% |
Femasys Inc. | 4.25 Million USD | 2028.054% |
GlucoTrack, Inc. | 196 Thousand USD | 41987.755% |
Harvard Bioscience, Inc. | 30.7 Million USD | 367.392% |
Hologic, Inc. | 2.49 Billion USD | 103.288% |
ICU Medical, Inc. | 1.57 Billion USD | 105.204% |
KORU Medical Systems, Inc. | 3.65 Million USD | 2347.515% |
LeMaitre Vascular, Inc. | 16.62 Million USD | 593.864% |
Innovative Eyewear, Inc. | - USD | Infinity% |
Innovative Eyewear, Inc. | - USD | Infinity% |
Masimo Corporation | 871.7 Million USD | 109.418% |
Microbot Medical Inc. | 40 Thousand USD | 205350.0% |
Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | 1787991.986% |
Merit Medical Systems, Inc. | 823.01 Million USD | 109.976% |
Nephros, Inc. | 1.39 Million USD | 6006.475% |
NovoCure Limited | 596.24 Million USD | 113.77% |
NEXGEL, Inc. | 513 Thousand USD | 16103.899% |
NEXGEL, Inc. | 513 Thousand USD | 16103.899% |
Singular Genomics Systems, Inc. | 67.52 Million USD | 221.586% |
OraSure Technologies, Inc. | 11.38 Million USD | 820.934% |
Pro-Dex, Inc. | 7.53 Million USD | 1189.437% |
Pulse Biosciences, Inc. | 8.08 Million USD | 1115.335% |
Predictive Oncology Inc. | 2.18 Million USD | 3850.607% |
Precision Optics Corporation, Inc. | 1.93 Million USD | 4336.392% |
QuidelOrtho Corporation | 2.27 Billion USD | 103.61% |
Repligen Corporation | 510.14 Million USD | 116.094% |
Sanara MedTech Inc. | 9.11 Million USD | 1000.899% |
STAAR Surgical Company | 31.46 Million USD | 360.908% |
Sharps Technology, Inc. | - USD | Infinity% |
Utah Medical Products, Inc. | 295 Thousand USD | 27930.508% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 104.571% |
Jin Medical International Ltd. | - USD | Infinity% |